home / stock / ontx / ontx news

ONTX News and Press, Onconova Therapeutics Inc. From 06/05/23

Stock Information
Company Name: Onconova Therapeutics Inc.
Stock Symbol: ONTX
Market: NASDAQ
Website: onconova.com
Menu
ONTX ONTX Quote ONTX Short ONTX News ONTX Articles ONTX Message Board
Get ONTX Alerts

News, Short Squeeze, Breakout and More Instantly...
ONTX - Onconova Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Annual Meeting

NEWTOWN, Pa., June 05, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced the presentation of a Trials in Progres...
ONTX - Onconova Therapeutics Announces Dosing of First Participant in Investigator-Sponsored Phase 2 Trial of Rigosertib Plus Pembrolizumab in Metastatic Melanoma Patients Refractory to Immune Checkpoint Blockade

NEWTOWN, Pa., May 25, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the first participant has been dose...

ONTX - Onconova Therapeutics, Inc. (ONTX) Q1 2023 Earnings Call Transcript

2023-05-15 21:11:06 ET Onconova Therapeutics, Inc. (ONTX) Q1 2023 Earnings Conference Call May 15, 2023 04:30 PM ET Company Participants Bruce Mackle - Managing Director, LifeSci Advisors Steven Fruchtman - President and Chief Executive Officer Michael Saunders -...

ONTX - Onconova Therapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $0.06M misses by $0.02M

2023-05-15 16:21:00 ET Onconova Therapeutics press release ( NASDAQ: ONTX ): Q1 GAAP EPS of -$0.28 beats by $0.02 . Revenue of $0.06M (flat Y/Y) misses by $0.02M . For further details see: Onconova Therapeutics GAAP EPS of -$0.28 beats by $0.02, revenue o...
ONTX - Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

NEWTOWN, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced financial results for the three ...

ONTX - Notable earnings after Monday's close

2023-05-14 17:35:54 ET Major earnings expected after the bell on Monday include: Danaos Corporation ( DAC ) Canoo ( GOEV ) Arrival ( ARVL ) Cara Therapeutics ( CARA ) Fortuna Silver Mines ( FSM ) For further details see: Notable earnings a...

ONTX - Onconova Therapeutics Q1 Earnings Preview

2023-05-14 17:35:00 ET Onconova Therapeutics ( NASDAQ: ONTX ) is scheduled to announce Q1 earnings results on Monday, May 15th, after market close. The consensus EPS Estimate is -$0.30 (-50.0% Y/Y) and the consensus Revenue Estimate is $0.08M (+33.3% Y/Y). Over the las...
ONTX - Onconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial Cancer

Showcase to feature presentations by key opinion leaders Drs. Gaël Roué and Bhavana Pothuri Showcase to take place on May 18, 2023 at 11:00 a.m. ET NEWTOWN, Pa., May 12, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”...

ONTX - Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer

Prior data provide clinical proof-of-concept for narazaciclib’s mechanism of action in endometrial cancer Preliminary data from trial’s Phase 1 portion expected in 4Q 2023 NEWTOWN, Pa., May 11, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (&#x...

ONTX - Onconova Therapeutics to Present at the ISID International Epidermolysis Bullosa Symposium

NEWTOWN, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced a...
Previous 10 Next 10